BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement
Pictured: Bristol Myers Squibb office in Brisbane, California/iStock, hapabapa Bristol Myers Squibb has signed a $380 million worldwide capacity reservation and supply deal with manufacturer Cellares to bolster the pharma’s CAR-T cell therapy …